GLP1R and irritable bowel syndrome: In addition, the GLP-1 analog liraglutide markedly attenuated experimentally induced visceral hypersensitivity in rat models [65], further supporting the concept that peripheral GPCR modulation may offer effective and safer pain control in IBS.